Detalles de la búsqueda
1.
IELSG38: phase II trial of front-line chlorambucil plus subcutaneous rituximab induction and maintenance in mucosa-associated lymphoid tissue lymphoma.
Haematologica
; 2024 Feb 22.
Artículo
en Inglés
| MEDLINE | ID: mdl-38385243
2.
Preexisting and treatment-emergent autoimmune cytopenias in patients with CLL treated with targeted drugs.
Blood
; 137(25): 3507-3517, 2021 06 24.
Artículo
en Inglés
| MEDLINE | ID: mdl-33651883
3.
High rate of durable responses with undetectable minimal residual disease with front-line venetoclax and rituximab in young, fit patients with chronic lymphocytic leukemia and an adverse biological profile: results of the GIMEMA phase II LLC1518 - VERITAS study.
Haematologica
; 108(8): 2091-2100, 2023 08 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-36632738
4.
Autologous stem-cell transplantation as consolidation of first-line chemotherapy in patients with peripheral T-cell lymphoma: a multicenter GELTAMO/FIL study.
Haematologica
; 107(11): 2675-2684, 2022 11 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-35320921
5.
Efficacy of rituximab in anti-myelin-associated glycoprotein demyelinating polyneuropathy: Clinical, hematological and neurophysiological correlations during 2 years of follow-up.
Eur J Neurol
; 29(12): 3611-3622, 2022 Dec.
Artículo
en Inglés
| MEDLINE | ID: mdl-36083713
6.
Phase 3 Trial of Ibrutinib plus Rituximab in Waldenström's Macroglobulinemia.
N Engl J Med
; 378(25): 2399-2410, 2018 Jun 21.
Artículo
en Inglés
| MEDLINE | ID: mdl-29856685
7.
Early progression as a predictor of survival in marginal zone lymphomas: an analysis from the FIL-NF10 study.
Blood
; 134(10): 798-801, 2019 09 05.
Artículo
en Inglés
| MEDLINE | ID: mdl-31292118
8.
Induction therapy with the MATRix regimen in patients with newly diagnosed primary diffuse large B-cell lymphoma of the central nervous system - an international study of feasibility and efficacy in routine clinical practice.
Br J Haematol
; 189(5): 879-887, 2020 06.
Artículo
en Inglés
| MEDLINE | ID: mdl-31997308
9.
Highly sensitive MYD88L265P mutation detection by droplet digital polymerase chain reaction in Waldenström macroglobulinemia.
Haematologica
; 103(6): 1029-1037, 2018 06.
Artículo
en Inglés
| MEDLINE | ID: mdl-29567768
10.
Role of chemotherapy in the treatment of chronic lymphocytic leukemia in the era of targeted therapies in Italy. A Campus CLL network report.
Hematol Oncol
; 41(1): 201-204, 2023 02.
Artículo
en Inglés
| MEDLINE | ID: mdl-35849302
11.
Yttrium-90 ibritumomab tiuxetan (Zevalin) followed by BEAM (Z-BEAM) conditioning regimen and autologous stem cell transplantation (ASCT) in relapsed or refractory high-risk B-cell non-Hodgkin lymphoma (NHL): a single institution Italian experience.
Ann Hematol
; 97(9): 1619-1626, 2018 Sep.
Artículo
en Inglés
| MEDLINE | ID: mdl-29663029
12.
Chronic lymphocytic leukemia management in Italy during the COVID-19 pandemic: a Campus CLL report.
Blood
; 136(6): 763-766, 2020 08 06.
Artículo
en Inglés
| MEDLINE | ID: mdl-32559271
13.
Brentuximab vedotin in the treatment of relapsed/refractory CD30+ peripheral T-cell lymphoma: A FIL phase 2 study.
Hematol Oncol
; 40(2): 307-309, 2022 04.
Artículo
en Inglés
| MEDLINE | ID: mdl-35023190
14.
Management of chronic lymphocytic leukemia in Italy during a one year of the COVID-19 pandemic and at the start of the vaccination program. A Campus CLL report.
Hematol Oncol
; 39(4): 570-574, 2021 Oct.
Artículo
en Inglés
| MEDLINE | ID: mdl-34258787
15.
Chlorambucil plus rituximab with or without maintenance rituximab as first-line treatment for elderly chronic lymphocytic leukemia patients.
Am J Hematol
; 89(5): 480-6, 2014 May.
Artículo
en Inglés
| MEDLINE | ID: mdl-24415640
16.
Second Neoplasms in Italian Patients with Hairy Cell Leukemia after Treatment with Cladribine: A Multicenter Investigation and Literature Review.
Cancers (Basel)
; 16(8)2024 Apr 11.
Artículo
en Inglés
| MEDLINE | ID: mdl-38672557
17.
IELSG30 phase 2 trial: intravenous and intrathecal CNS prophylaxis in primary testicular diffuse large B-cell lymphoma.
Blood Adv
; 8(6): 1541-1549, 2024 Mar 26.
Artículo
en Inglés
| MEDLINE | ID: mdl-38181782
18.
Lenalidomide plus cyclophosphamide, doxorubicin, vincristine, prednisone and rituximab is safe and effective in untreated, elderly patients with diffuse large B-cell lymphoma: a phase I study by the Fondazione Italiana Linfomi.
Haematologica
; 98(11): 1732-8, 2013 Nov.
Artículo
en Inglés
| MEDLINE | ID: mdl-23812930
19.
Romidepsin-CHOEP followed by high-dose chemotherapy and stem-cell transplantation in untreated Peripheral T-Cell Lymphoma: results of the PTCL13 phase Ib/II study.
Leukemia
; 37(2): 433-440, 2023 02.
Artículo
en Inglés
| MEDLINE | ID: mdl-36653509
20.
Salvage treatment with lenalidomide and dexamethasone in relapsed/refractory mantle cell lymphoma: clinical results and effects on microenvironment and neo-angiogenic biomarkers.
Haematologica
; 97(3): 416-22, 2012 Mar.
Artículo
en Inglés
| MEDLINE | ID: mdl-22058200